Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019
BackgroundCarbapenemase-producing are increasing worldwide. In recent years, an increase in OXA-244-producing isolates has been seen in the national surveillance of carbapenemase-producing organisms in Denmark.AimMolecular characterisation and epidemiological investigation of OXA-244-producing isola...
Gespeichert in:
Veröffentlicht in: | Euro surveillance : bulletin européen sur les maladies transmissibles 2020-05, Vol.25 (18), p.1 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 18 |
container_start_page | 1 |
container_title | Euro surveillance : bulletin européen sur les maladies transmissibles |
container_volume | 25 |
creator | Hammerum, Anette M Porsbo, Lone Jannok Hansen, Frank Roer, Louise Kaya, Hülya Henius, Anna Møller, Karina Lauenborg Justesen, Ulrik S Søes, Lillian Røder, Bent L Thomsen, Philip K Wang, Mikala Søndergaard, Turid Snekloth Holzknecht, Barbara Juliane Østergaard, Claus Kjerulf, Anne Kristensen, Brian Hasman, Henrik |
description | BackgroundCarbapenemase-producing
are increasing worldwide. In recent years, an increase in OXA-244-producing
isolates has been seen in the national surveillance of carbapenemase-producing organisms in Denmark.AimMolecular characterisation and epidemiological investigation of OXA-244-producing
isolates from January 2016 to August 2019.MethodsFor the epidemiological investigation, data from the Danish National Patient Registry and the Danish register of civil registration were used together with data from phone interviews with patients. Isolates were characterised by analysing whole genome sequences for resistance genes, MLST and core genome MLST (cgMLST).ResultsIn total, 24 OXA-244-producing
isolates were obtained from 23 patients. Among the 23 patients, 13 reported travelling before detection of the
isolates, with seven having visited countries in Northern Africa. Fifteen isolates also carried an extended-spectrum beta-lactamase gene and one had a plasmid-encoded AmpC gene. The most common detected sequence type (ST) was ST38, followed by ST69, ST167, ST10, ST361 and ST3268. Three clonal clusters were detected by cgMLST, but none of these clusters seemed to reflect nosocomial transmission in Denmark.ConclusionImport of OXA-244
isolates from travelling abroad seems likely for the majority of cases. Community sources were also possible, as many of the patients had no history of hospitalisation and many of the
isolates belonged to STs that are present in the community. It was not possible to point at a single country or a community source as risk factor for acquiring OXA-244-producing
. |
doi_str_mv | 10.2807/1560-7917.ES.2020.25.18.1900742 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7219033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2405658268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-1ebf711cf2712a7ee48d252e68b541312e07f3e99421202d3ddb1b53186f91653</originalsourceid><addsrcrecordid>eNpdkUtv1DAUhS0EomXgLyBLLGDRBL_y2oBGZVpAlbqYVmJnOc5NxiVjD3Y8Upf88zrqdFRY-XV8dM_5EPpISc5qUn2mRUmyqqFVvlrnjLB0XeS0zmlDSCXYC3R6VLx8tj9Bb0K4I0Rw0rDX6IQzQQgv-Sn6u45-D2YcldWAXY-vfy0zJkS2866L2tgBr4LegDd6YxTWbjRY2Q7DznSwNW50g9HY2D2EyQxqMs7OLloFCGf4G9it8r_P8E9lo_L3mBFa4snhZRximOZj8xa96tUY4N1hXaDbi9XN-ffs6vryx_nyKtOibKaMQttXlOqeVZSpCkDUHSsYlHVbCMopA1L1HJpGMJqK6XjXtbQtOK3LvqFlwRfoy6PvLrZb6DTYyatR7rxJI95Lp4z898WajRzcXlYstct5Mvh0MPDuT0x55dYEDXN14GKQqVMmki71ukAf_pPeuehtijerirKoWVkn1ddHlfYuBA_9cRhK5IxbzgDlDFCu1nLGLVkhaS0PuJPD--eZjv-f-PIHyyqlzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405658268</pqid></control><display><type>article</type><title>Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hammerum, Anette M ; Porsbo, Lone Jannok ; Hansen, Frank ; Roer, Louise ; Kaya, Hülya ; Henius, Anna ; Møller, Karina Lauenborg ; Justesen, Ulrik S ; Søes, Lillian ; Røder, Bent L ; Thomsen, Philip K ; Wang, Mikala ; Søndergaard, Turid Snekloth ; Holzknecht, Barbara Juliane ; Østergaard, Claus ; Kjerulf, Anne ; Kristensen, Brian ; Hasman, Henrik</creator><creatorcontrib>Hammerum, Anette M ; Porsbo, Lone Jannok ; Hansen, Frank ; Roer, Louise ; Kaya, Hülya ; Henius, Anna ; Møller, Karina Lauenborg ; Justesen, Ulrik S ; Søes, Lillian ; Røder, Bent L ; Thomsen, Philip K ; Wang, Mikala ; Søndergaard, Turid Snekloth ; Holzknecht, Barbara Juliane ; Østergaard, Claus ; Kjerulf, Anne ; Kristensen, Brian ; Hasman, Henrik</creatorcontrib><description>BackgroundCarbapenemase-producing
are increasing worldwide. In recent years, an increase in OXA-244-producing
isolates has been seen in the national surveillance of carbapenemase-producing organisms in Denmark.AimMolecular characterisation and epidemiological investigation of OXA-244-producing
isolates from January 2016 to August 2019.MethodsFor the epidemiological investigation, data from the Danish National Patient Registry and the Danish register of civil registration were used together with data from phone interviews with patients. Isolates were characterised by analysing whole genome sequences for resistance genes, MLST and core genome MLST (cgMLST).ResultsIn total, 24 OXA-244-producing
isolates were obtained from 23 patients. Among the 23 patients, 13 reported travelling before detection of the
isolates, with seven having visited countries in Northern Africa. Fifteen isolates also carried an extended-spectrum beta-lactamase gene and one had a plasmid-encoded AmpC gene. The most common detected sequence type (ST) was ST38, followed by ST69, ST167, ST10, ST361 and ST3268. Three clonal clusters were detected by cgMLST, but none of these clusters seemed to reflect nosocomial transmission in Denmark.ConclusionImport of OXA-244
isolates from travelling abroad seems likely for the majority of cases. Community sources were also possible, as many of the patients had no history of hospitalisation and many of the
isolates belonged to STs that are present in the community. It was not possible to point at a single country or a community source as risk factor for acquiring OXA-244-producing
.</description><identifier>ISSN: 1560-7917</identifier><identifier>ISSN: 1025-496X</identifier><identifier>EISSN: 1560-7917</identifier><identifier>DOI: 10.2807/1560-7917.ES.2020.25.18.1900742</identifier><identifier>PMID: 32400363</identifier><language>eng</language><publisher>Sweden: Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - therapeutic use ; Bacterial infections ; beta-Lactamases - genetics ; Community-Acquired Infections - epidemiology ; Community-Acquired Infections - microbiology ; Cross Infection - epidemiology ; Cross Infection - microbiology ; Denmark - epidemiology ; E coli ; Epidemiology ; Escherichia coli - enzymology ; Escherichia coli - genetics ; Escherichia coli - isolation & purification ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - epidemiology ; Escherichia coli Infections - microbiology ; Genetic diversity ; Genomes ; Health surveillance ; Humans ; Middle Aged ; Molecular Epidemiology ; Multilocus Sequence Typing ; Plasmids - genetics ; Polymerase Chain Reaction ; Surveillance ; Travel ; Whole Genome Sequencing</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2020-05, Vol.25 (18), p.1</ispartof><rights>Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) May 7, 2020</rights><rights>This article is copyright of the authors or their affiliated institutions, 2020. 2020 The authors or their affiliated institutions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-1ebf711cf2712a7ee48d252e68b541312e07f3e99421202d3ddb1b53186f91653</citedby><cites>FETCH-LOGICAL-c469t-1ebf711cf2712a7ee48d252e68b541312e07f3e99421202d3ddb1b53186f91653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219033/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219033/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32400363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hammerum, Anette M</creatorcontrib><creatorcontrib>Porsbo, Lone Jannok</creatorcontrib><creatorcontrib>Hansen, Frank</creatorcontrib><creatorcontrib>Roer, Louise</creatorcontrib><creatorcontrib>Kaya, Hülya</creatorcontrib><creatorcontrib>Henius, Anna</creatorcontrib><creatorcontrib>Møller, Karina Lauenborg</creatorcontrib><creatorcontrib>Justesen, Ulrik S</creatorcontrib><creatorcontrib>Søes, Lillian</creatorcontrib><creatorcontrib>Røder, Bent L</creatorcontrib><creatorcontrib>Thomsen, Philip K</creatorcontrib><creatorcontrib>Wang, Mikala</creatorcontrib><creatorcontrib>Søndergaard, Turid Snekloth</creatorcontrib><creatorcontrib>Holzknecht, Barbara Juliane</creatorcontrib><creatorcontrib>Østergaard, Claus</creatorcontrib><creatorcontrib>Kjerulf, Anne</creatorcontrib><creatorcontrib>Kristensen, Brian</creatorcontrib><creatorcontrib>Hasman, Henrik</creatorcontrib><title>Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><addtitle>Euro Surveill</addtitle><description>BackgroundCarbapenemase-producing
are increasing worldwide. In recent years, an increase in OXA-244-producing
isolates has been seen in the national surveillance of carbapenemase-producing organisms in Denmark.AimMolecular characterisation and epidemiological investigation of OXA-244-producing
isolates from January 2016 to August 2019.MethodsFor the epidemiological investigation, data from the Danish National Patient Registry and the Danish register of civil registration were used together with data from phone interviews with patients. Isolates were characterised by analysing whole genome sequences for resistance genes, MLST and core genome MLST (cgMLST).ResultsIn total, 24 OXA-244-producing
isolates were obtained from 23 patients. Among the 23 patients, 13 reported travelling before detection of the
isolates, with seven having visited countries in Northern Africa. Fifteen isolates also carried an extended-spectrum beta-lactamase gene and one had a plasmid-encoded AmpC gene. The most common detected sequence type (ST) was ST38, followed by ST69, ST167, ST10, ST361 and ST3268. Three clonal clusters were detected by cgMLST, but none of these clusters seemed to reflect nosocomial transmission in Denmark.ConclusionImport of OXA-244
isolates from travelling abroad seems likely for the majority of cases. Community sources were also possible, as many of the patients had no history of hospitalisation and many of the
isolates belonged to STs that are present in the community. It was not possible to point at a single country or a community source as risk factor for acquiring OXA-244-producing
.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial infections</subject><subject>beta-Lactamases - genetics</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - microbiology</subject><subject>Denmark - epidemiology</subject><subject>E coli</subject><subject>Epidemiology</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - isolation & purification</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - epidemiology</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Genetic diversity</subject><subject>Genomes</subject><subject>Health surveillance</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Molecular Epidemiology</subject><subject>Multilocus Sequence Typing</subject><subject>Plasmids - genetics</subject><subject>Polymerase Chain Reaction</subject><subject>Surveillance</subject><subject>Travel</subject><subject>Whole Genome Sequencing</subject><issn>1560-7917</issn><issn>1025-496X</issn><issn>1560-7917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtv1DAUhS0EomXgLyBLLGDRBL_y2oBGZVpAlbqYVmJnOc5NxiVjD3Y8Upf88zrqdFRY-XV8dM_5EPpISc5qUn2mRUmyqqFVvlrnjLB0XeS0zmlDSCXYC3R6VLx8tj9Bb0K4I0Rw0rDX6IQzQQgv-Sn6u45-D2YcldWAXY-vfy0zJkS2866L2tgBr4LegDd6YxTWbjRY2Q7DznSwNW50g9HY2D2EyQxqMs7OLloFCGf4G9it8r_P8E9lo_L3mBFa4snhZRximOZj8xa96tUY4N1hXaDbi9XN-ffs6vryx_nyKtOibKaMQttXlOqeVZSpCkDUHSsYlHVbCMopA1L1HJpGMJqK6XjXtbQtOK3LvqFlwRfoy6PvLrZb6DTYyatR7rxJI95Lp4z898WajRzcXlYstct5Mvh0MPDuT0x55dYEDXN14GKQqVMmki71ukAf_pPeuehtijerirKoWVkn1ddHlfYuBA_9cRhK5IxbzgDlDFCu1nLGLVkhaS0PuJPD--eZjv-f-PIHyyqlzg</recordid><startdate>20200507</startdate><enddate>20200507</enddate><creator>Hammerum, Anette M</creator><creator>Porsbo, Lone Jannok</creator><creator>Hansen, Frank</creator><creator>Roer, Louise</creator><creator>Kaya, Hülya</creator><creator>Henius, Anna</creator><creator>Møller, Karina Lauenborg</creator><creator>Justesen, Ulrik S</creator><creator>Søes, Lillian</creator><creator>Røder, Bent L</creator><creator>Thomsen, Philip K</creator><creator>Wang, Mikala</creator><creator>Søndergaard, Turid Snekloth</creator><creator>Holzknecht, Barbara Juliane</creator><creator>Østergaard, Claus</creator><creator>Kjerulf, Anne</creator><creator>Kristensen, Brian</creator><creator>Hasman, Henrik</creator><general>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</general><general>European Centre for Disease Prevention and Control (ECDC)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200507</creationdate><title>Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019</title><author>Hammerum, Anette M ; Porsbo, Lone Jannok ; Hansen, Frank ; Roer, Louise ; Kaya, Hülya ; Henius, Anna ; Møller, Karina Lauenborg ; Justesen, Ulrik S ; Søes, Lillian ; Røder, Bent L ; Thomsen, Philip K ; Wang, Mikala ; Søndergaard, Turid Snekloth ; Holzknecht, Barbara Juliane ; Østergaard, Claus ; Kjerulf, Anne ; Kristensen, Brian ; Hasman, Henrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-1ebf711cf2712a7ee48d252e68b541312e07f3e99421202d3ddb1b53186f91653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial infections</topic><topic>beta-Lactamases - genetics</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - microbiology</topic><topic>Denmark - epidemiology</topic><topic>E coli</topic><topic>Epidemiology</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - isolation & purification</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - epidemiology</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Genetic diversity</topic><topic>Genomes</topic><topic>Health surveillance</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Molecular Epidemiology</topic><topic>Multilocus Sequence Typing</topic><topic>Plasmids - genetics</topic><topic>Polymerase Chain Reaction</topic><topic>Surveillance</topic><topic>Travel</topic><topic>Whole Genome Sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammerum, Anette M</creatorcontrib><creatorcontrib>Porsbo, Lone Jannok</creatorcontrib><creatorcontrib>Hansen, Frank</creatorcontrib><creatorcontrib>Roer, Louise</creatorcontrib><creatorcontrib>Kaya, Hülya</creatorcontrib><creatorcontrib>Henius, Anna</creatorcontrib><creatorcontrib>Møller, Karina Lauenborg</creatorcontrib><creatorcontrib>Justesen, Ulrik S</creatorcontrib><creatorcontrib>Søes, Lillian</creatorcontrib><creatorcontrib>Røder, Bent L</creatorcontrib><creatorcontrib>Thomsen, Philip K</creatorcontrib><creatorcontrib>Wang, Mikala</creatorcontrib><creatorcontrib>Søndergaard, Turid Snekloth</creatorcontrib><creatorcontrib>Holzknecht, Barbara Juliane</creatorcontrib><creatorcontrib>Østergaard, Claus</creatorcontrib><creatorcontrib>Kjerulf, Anne</creatorcontrib><creatorcontrib>Kristensen, Brian</creatorcontrib><creatorcontrib>Hasman, Henrik</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammerum, Anette M</au><au>Porsbo, Lone Jannok</au><au>Hansen, Frank</au><au>Roer, Louise</au><au>Kaya, Hülya</au><au>Henius, Anna</au><au>Møller, Karina Lauenborg</au><au>Justesen, Ulrik S</au><au>Søes, Lillian</au><au>Røder, Bent L</au><au>Thomsen, Philip K</au><au>Wang, Mikala</au><au>Søndergaard, Turid Snekloth</au><au>Holzknecht, Barbara Juliane</au><au>Østergaard, Claus</au><au>Kjerulf, Anne</au><au>Kristensen, Brian</au><au>Hasman, Henrik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><addtitle>Euro Surveill</addtitle><date>2020-05-07</date><risdate>2020</risdate><volume>25</volume><issue>18</issue><spage>1</spage><pages>1-</pages><issn>1560-7917</issn><issn>1025-496X</issn><eissn>1560-7917</eissn><abstract>BackgroundCarbapenemase-producing
are increasing worldwide. In recent years, an increase in OXA-244-producing
isolates has been seen in the national surveillance of carbapenemase-producing organisms in Denmark.AimMolecular characterisation and epidemiological investigation of OXA-244-producing
isolates from January 2016 to August 2019.MethodsFor the epidemiological investigation, data from the Danish National Patient Registry and the Danish register of civil registration were used together with data from phone interviews with patients. Isolates were characterised by analysing whole genome sequences for resistance genes, MLST and core genome MLST (cgMLST).ResultsIn total, 24 OXA-244-producing
isolates were obtained from 23 patients. Among the 23 patients, 13 reported travelling before detection of the
isolates, with seven having visited countries in Northern Africa. Fifteen isolates also carried an extended-spectrum beta-lactamase gene and one had a plasmid-encoded AmpC gene. The most common detected sequence type (ST) was ST38, followed by ST69, ST167, ST10, ST361 and ST3268. Three clonal clusters were detected by cgMLST, but none of these clusters seemed to reflect nosocomial transmission in Denmark.ConclusionImport of OXA-244
isolates from travelling abroad seems likely for the majority of cases. Community sources were also possible, as many of the patients had no history of hospitalisation and many of the
isolates belonged to STs that are present in the community. It was not possible to point at a single country or a community source as risk factor for acquiring OXA-244-producing
.</abstract><cop>Sweden</cop><pub>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</pub><pmid>32400363</pmid><doi>10.2807/1560-7917.ES.2020.25.18.1900742</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1560-7917 |
ispartof | Euro surveillance : bulletin européen sur les maladies transmissibles, 2020-05, Vol.25 (18), p.1 |
issn | 1560-7917 1025-496X 1560-7917 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7219033 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Adult Aged Aged, 80 and over Anti-Bacterial Agents - therapeutic use Bacterial infections beta-Lactamases - genetics Community-Acquired Infections - epidemiology Community-Acquired Infections - microbiology Cross Infection - epidemiology Cross Infection - microbiology Denmark - epidemiology E coli Epidemiology Escherichia coli - enzymology Escherichia coli - genetics Escherichia coli - isolation & purification Escherichia coli Infections - drug therapy Escherichia coli Infections - epidemiology Escherichia coli Infections - microbiology Genetic diversity Genomes Health surveillance Humans Middle Aged Molecular Epidemiology Multilocus Sequence Typing Plasmids - genetics Polymerase Chain Reaction Surveillance Travel Whole Genome Sequencing |
title | Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A28%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surveillance%20of%20OXA-244-producing%20Escherichia%20coli%20and%20epidemiologic%20investigation%20of%20cases,%20Denmark,%20January%202016%20to%20August%202019&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Hammerum,%20Anette%20M&rft.date=2020-05-07&rft.volume=25&rft.issue=18&rft.spage=1&rft.pages=1-&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/1560-7917.ES.2020.25.18.1900742&rft_dat=%3Cproquest_pubme%3E2405658268%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2405658268&rft_id=info:pmid/32400363&rfr_iscdi=true |